venlafaxine hydrochloride has been researched along with Eye Disorders in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boog, G; Gommier, B; Jacopin-Bruneau, L; Pierre, F | 1 |
Pfuhlmann, B; Reif, A | 1 |
Domula, M; Felber, W; Gallinat, J; Lang, UE; Schmidt, E; Schulze, D; Stogowski, D; Tugtekin, SM | 1 |
3 other study(ies) available for venlafaxine hydrochloride and Eye Disorders
Article | Year |
---|---|
[Idiopathic intracranial hypertension and pregnancy. A report of two cases].
Topics: Acetazolamide; Adult; Brain; Cyclohexanols; Drug Overdose; Eye Diseases; Female; Fetal Growth Retardation; Gestational Age; Humans; Intracranial Hypertension; Labor, Induced; Magnetic Resonance Angiography; Oligohydramnios; Pregnancy; Pregnancy Complications; Spinal Puncture; Suicide, Attempted; Venlafaxine Hydrochloride | 2010 |
Venlafaxine and reversible blepharoedema.
Topics: Adult; Cyclohexanols; Edema; Eye Diseases; Female; Humans; Hyponatremia; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2002 |
Charles Bonnet Syndrome: successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors.
Topics: Aged; Cognition; Cyclohexanols; Eye Diseases; Female; Hallucinations; Humans; Selective Serotonin Reuptake Inhibitors; Syndrome; Treatment Outcome; Venlafaxine Hydrochloride; Vision Disorders | 2007 |